Artiva Biotherapeutics

Sr. Director/ED, Medical Affairs Medical Communications Publications

Artiva Biotherapeutics$250K — $300K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Advanced degree in a scientific or clinical field (PhD, PharmD, DO, MD) required.
  • 8+ years of experience in medical communications or publications in biotech/pharmaceuticals.
  • Deep understanding of rheumatology, immunology, and complex cell therapies (e.g., CAR-T, TCEs).
  • Expert in ICMJE guidelines, GPP guidelines, and Sunshine Act/EFPIA disclosure.
  • Experience leading cross-functional teams and managing multiple projects.

Responsibilities

  • Develop and execute global publication plans for rheumatology, immunology, and cell therapy.
  • Collaborate to ensure timely communication of clinical trial results at major congresses.
  • Ensure compliance with publication standards and corporate policies.
  • Oversee drafting and medical review of scientific publications.
  • Direct external agencies and manage budgets for deliverables.
  • Plan comprehensive communication strategies for major congresses.
  • Lead development of congress-specific materials and learning experiences.
  • Monitor and translate competitive intelligence into actionable strategies.

Benefits

  • Modern and well-equipped facilities.
  • Collaborative and innovative work culture.
  • Comprehensive medical, dental, and vision coverage.
  • Group Life Insurance and Long-Term Disability (LTD).
  • 401(k) Retirement Plan with company contributions.
  • Employee Assistance Program (EAP) for personal support.
  • Flexible Spending Account (FSA) options.
  • Paid Time Off and company-paid holidays, including a holiday week at year-end.
  • Recognition program for trading points for rewards.
Full Job Description
Job Summary: The Sr. Director/Executive Director, Medical Communications Publications will drive the end-to-end strategic planning and execution of scientific publications across the AlloNK platform and lead comprehensive congress activities. Operating at the intersection of R&D and Medical Affairs, you will translate complex clinical data in rheumatology, cell therapy, and immunology into compelling, compliant, and high-impact scientific communications. We are looking for someone who is equally comfortable setting up the strategy and rolling up their sleeves - a hands-on leader who can build and inspire a team while delivering results. Key Responsibilities • Publication Planning & Strategy: Develop and execute global/regional publication plans (abstracts, posters, manuscripts, reviews) for rheumatology, immunology, and cell therapy audiences. • Data Dissemination: Collaborate with Clinical Development, Medical Affairs, and principal investigators to ensure timely, accurate dissemination of clinical trial results at major scientific congresses. • Compliance & Governance: Ensure all publications strictly adhere to Good Publication Practice (GPP), ICMJE authorship guidelines, and corporate compliance standards. • Content Development & Review: Oversee the drafting, editing, and medical review of scientific publications and related congress materials, ensuring scientific accuracy and balanced data presentation. • Agency Management: Direct external medical communications agencies, medical writers, and vendor budgets to ensure on-time, high-quality deliverables. • Congress Planning & Strategy: Architect the comprehensive pre- and post-congress communication strategy for major rheumatology and immunology meetings (e.g., ACR, EULAR, ISSJD, CCR) including congress playbooks and post-congress debriefs. • Medical Affairs Activities: Lead the development of congress-specific materials, including scientific symposia, medical booth content, and interactive learning stations. • Competitive Intelligence: Monitor emerging clinical data, treatment paradigm shifts, and competitor activity at key meetings, translating these external insights into actionable communication strategies. Qualifications • Advanced scientific or clinical degree (e.g., PhD, PharmD, DO, or MD) required. • 8+ years of progressive medical communications or publications experience within the biotech or pharmaceutical industry. • Proven track record and deep understanding of rheumatology, immunology, and/or complex cell therapies (e.g., CAR-T, TCEs). • Expert knowledge of ICMJE guidelines, GPP guidelines, and the Sunshine Act/EFPIA disclosure requirements. • Demonstrated ability to lead cross-functional teams, build a medical communications and publications capability, manage and mentor junior staff, and manage multiple complex projects simultaneously. Preferred Skills • Experience utilizing publication management software (e.g., Datavision) to track publication progress and manage author review cycles. • Strong network of relationships with Key Opinion Leaders (KOLs) in rheumatology, immunology, and cell therapy. • Exceptional scientific storytelling ability and meticulous attention to detail. • ISMPP CMPP certification In addition to a great culture, we offer: • A beautiful facility • An entrepreneurial, highly collaborative, and innovative environment • Comprehensive benefits, including: • Medical, Dental, and Vision • Group Life Insurance • Long Term Disability (LTD) • 401(k) Retirement Plan • Employee Assistance Program (EAP) • Flexible Spending Account (FSA) • Paid Time Off (PTO) • Company paid holidays, including the year-end holiday week • Our recognition program, Bonus.ly, is where you can trade in points earned for things you want. Base Salary: $250,000 - 300,000. Exact compensation may vary based on level, skills, and experience.

About Artiva Biotherapeutics

Artiva Biotherapeutics is a clinical-stage biotechnology company developing a pipeline of novel, precisely targeted immuno-oncology therapies. The company's proprietary technology platform leverages a deep understanding of the biology of immune cells and their interactions with cancer cells to develop therapies that can selectively activate or suppress immune responses to cancer. Artiva's lead product candidate, AB-101, is a first-in-class, off-the-shelf, allogeneic cell therapy that targets solid tumors by activating natural killer (NK) cells. The company was founded in 2019 and is headquartered in South San Francisco, California.
Learn more about Artiva Biotherapeutics
Size
20 employees
Industry
Net Income
-$16
Founded
2019
NASDAQ

Similar Jobs

More Jobs at Artiva Biotherapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Sr. Director/ED, Medical Affairs Medical Communications Publications jobs: